• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可能由阿奇霉素引起的危及生命的心律失常,需要体外膜肺氧合支持:病例报告。

Possible Azithromycin-Induced Life-Threatening Arrhythmia Requiring Extracorporeal Membrane Oxygenation Support: A Case Report.

机构信息

Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Centre (KFSH&RC), Riyadh, Saudi Arabia.

出版信息

Am J Case Rep. 2020 Nov 12;21:e926951. doi: 10.12659/AJCR.926951.

DOI:10.12659/AJCR.926951
PMID:33180749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7669954/
Abstract

BACKGROUND Azithromycin is a commonly prescribed antibiotic due to several advantages, including the broad range of indications, spectrum of activity, favorable drug interaction profile, and convenience of dosing. Although azithromycin carries a black-box warning for QTc prolongation and ventricular arrhythmias, these are considered rare adverse effects. CASE REPORT We present the case of a 37-year-old woman who received azithromycin (500 mg) for follicular tonsillitis and was admitted for worsening of symptoms. On the same day of admission to a secondary hospital, she became unresponsive and had cardiac arrest, for which cardiopulmonary resuscitation (CPR) was performed for 26 min. As per the input from the secondary hospital, she had multiple ventricular tachycardia (VT) and ventricular fibrillation, and needed to be transferred to a tertiary care hospital for further management. Veno-arterial extracorporeal membrane oxygenation (ECMO) support was inserted to support her hemodynamics, and serial ECGs showed significant QT interval prolongation up to 600 msec. The QT prolongation resolved over 10 days and she was successfully weaned-off ECMO. CONCLUSIONS Although azithromycin has a relatively safe profile, it is also associated with life-threatening cardiac arrhythmias that may require surgical intervention to stabilize the patient hemodynamically.

摘要

背景

阿奇霉素由于具有广泛的适应证、活性谱、良好的药物相互作用特性和方便的给药方式等优点,因此被广泛应用于临床。尽管阿奇霉素存在导致 QTc 延长和室性心律失常的黑框警告,但这些被认为是罕见的不良反应。

病例报告

我们报告了一例 37 岁女性患者,因滤泡性扁桃体炎接受阿奇霉素(500mg)治疗,并因症状恶化而入院。在入住二级医院的同一天,她出现意识丧失和心脏骤停,进行了 26 分钟心肺复苏(CPR)。根据二级医院的信息,她出现了多次室性心动过速(VT)和心室颤动,需要转至三级护理医院进行进一步治疗。为了支持她的血液动力学,插入了静脉动脉体外膜肺氧合(ECMO)支持。连续心电图显示明显的 QT 间期延长,最高达 600ms。QT 延长在 10 天内得到缓解,她成功地脱离了 ECMO。

结论

尽管阿奇霉素具有相对安全的特性,但它也与危及生命的心律失常有关,可能需要手术干预以稳定患者的血液动力学。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ed/7669954/c1028af2402d/amjcaserep-21-e926951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ed/7669954/234ff6ddd68e/amjcaserep-21-e926951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ed/7669954/c1028af2402d/amjcaserep-21-e926951-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ed/7669954/234ff6ddd68e/amjcaserep-21-e926951-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20ed/7669954/c1028af2402d/amjcaserep-21-e926951-g002.jpg

相似文献

1
Possible Azithromycin-Induced Life-Threatening Arrhythmia Requiring Extracorporeal Membrane Oxygenation Support: A Case Report.可能由阿奇霉素引起的危及生命的心律失常,需要体外膜肺氧合支持:病例报告。
Am J Case Rep. 2020 Nov 12;21:e926951. doi: 10.12659/AJCR.926951.
2
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support.静脉-动脉体外膜肺氧合(VA-ECMO)用于紧急心脏支持。
J Crit Care. 2018 Apr;44:31-38. doi: 10.1016/j.jcrc.2017.10.011. Epub 2017 Oct 12.
3
Managing cardiac arrest with refractory ventricular fibrillation in the emergency department: Conventional cardiopulmonary resuscitation versus extracorporeal cardiopulmonary resuscitation.急诊科难治性心室颤动致心脏骤停的处理:常规心肺复苏与体外心肺复苏。
Resuscitation. 2015 Jul;92:70-6. doi: 10.1016/j.resuscitation.2015.04.016. Epub 2015 Apr 29.
4
Surviving refractory out-of-hospital ventricular fibrillation cardiac arrest: Critical care and extracorporeal membrane oxygenation management.存活的难治性院外室颤性心脏骤停:重症监护和体外膜氧合管理。
Resuscitation. 2018 Nov;132:47-55. doi: 10.1016/j.resuscitation.2018.08.030. Epub 2018 Aug 29.
5
Extracorporeal Life Support as a Rescue Measure for Managing Life-Threatening Arrythmia and Brugada Syndrome.体外生命支持作为治疗危及生命的心律失常和 Brugada 综合征的一种抢救措施。
J Extra Corpor Technol. 2017 Dec;49(4):312-316.
6
Extracorporeal Membrane Oxygenation to Support Life-Threatening Drug-Refractory Electrical Storm.体外膜肺氧合支持危及生命的药物难治性电风暴。
Crit Care Med. 2020 Oct;48(10):e856-e863. doi: 10.1097/CCM.0000000000004490.
7
Loperamide induced cardiac arrhythmia successfully supported with veno-arterial ECMO (VA-ECMO), molecular adsorbent recirculating system (MARS) and continuous renal replacement therapy (CRRT).洛哌丁胺引起的心律失常经静脉-动脉体外膜肺氧合(VA-ECMO)、分子吸附再循环系统(MARS)和持续肾脏替代治疗(CRRT)成功支持。
Clin Toxicol (Phila). 2019 Nov;57(11):1118-1122. doi: 10.1080/15563650.2019.1580370. Epub 2019 Feb 26.
8
An urgent open surgical approach for left ventricle venting during peripheral veno-arterial extracorporeal membrane oxygenation for refractory cardiac arrest: case report.外周静脉-动脉体外膜肺氧合治疗难治性心脏骤停时左心室排气的紧急开放手术方法:病例报告
Perfusion. 2020 Jan;35(1):82-85. doi: 10.1177/0267659119853949. Epub 2019 Jun 20.
9
Extracorporeal membrane oxygenation support for intractable primary arrhythmias and complete congenital heart block in newborns and infants: short-term and medium-term outcomes.体外膜肺氧合支持新生儿和婴儿难治性原发性心律失常和完全性先天性心脏传导阻滞:短期和中期结果。
Pediatr Crit Care Med. 2012 Jan;13(1):47-52. doi: 10.1097/PCC.0b013e3182196cb1.
10
Successful Resuscitation with Extracorporeal Membrane Oxygenation in a Case with Prolonged Cardiac Arrest.体外膜肺氧合成功复苏一例长时间心脏骤停患者
Chin Med Sci J. 2018 Jun 30;33(2):127-129. doi: 10.24920/31807.

引用本文的文献

1
Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles.开发阿奇霉素载药纳米粒的干粉制剂用于肺部给药。
J Pharm Pharm Sci. 2024 Oct 14;27:13635. doi: 10.3389/jpps.2024.13635. eCollection 2024.
2
The potential role of SARS-CoV-2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread.严重急性呼吸综合征冠状病毒 2 感染在急性冠状动脉综合征和 2 型心肌梗死(T2MI)中的潜在作用:交织传播。
Immun Inflamm Dis. 2023 Mar;11(3):e798. doi: 10.1002/iid3.798.

本文引用的文献

1
Failure to Treat Torsades de Pointes.未能治疗尖端扭转型室性心动过速。
Cardiol Res. 2012 Feb;3(1):34-36. doi: 10.4021/cr139w. Epub 2012 Jan 20.
2
The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.伴有严重右心室肥厚的肥厚型心肌病患者的临床特征、预后及遗传学特征
PLoS One. 2017 Mar 21;12(3):e0174118. doi: 10.1371/journal.pone.0174118. eCollection 2017.
3
Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting.
在法医环境下对100个心脏基因进行的不明原因猝死受害者基因调查。
Eur J Hum Genet. 2016 Dec;24(12):1797-1802. doi: 10.1038/ejhg.2016.118. Epub 2016 Sep 21.
4
Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.阿奇霉素、心血管风险、QTc间期延长、尖端扭转型室速及监管问题:基于病例报告研究的叙述性综述
Ther Adv Infect Dis. 2013 Oct;1(5):155-65. doi: 10.1177/2049936113501816.
5
Sudden cardiac arrest in a patient on chronic methadone after the addition of azithromycin.慢性美沙酮治疗患者加用阿奇霉素后发生心搏骤停。
Am J Med Sci. 2013 Feb;345(2):160-2. doi: 10.1097/MAJ.0b013e318266e7af.
6
Azithromycin and the risk of cardiovascular death.阿奇霉素与心血管死亡风险。
N Engl J Med. 2012 May 17;366(20):1881-90. doi: 10.1056/NEJMoa1003833.
7
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.与遗传性 J 波综合征和心源性猝死相关的心脏 L 型钙通道突变。
Heart Rhythm. 2010 Dec;7(12):1872-82. doi: 10.1016/j.hrthm.2010.08.026. Epub 2010 Oct 14.
8
Drug-induced QT prolongation and sudden death.药物诱导的QT间期延长与猝死。
Mo Med. 2010 Jan-Feb;107(1):53-8.
9
Azithromycin-induced torsade de pointes.阿奇霉素诱发的尖端扭转型室性心动过速。
Pacing Clin Electrophysiol. 2007 Dec;30(12):1579-82. doi: 10.1111/j.1540-8159.2007.00912.x.
10
Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors.阿奇霉素在无其他已知诱发因素的情况下导致QT间期延长和尖端扭转型室性心动过速。
J Interv Card Electrophysiol. 2007 Apr;18(3):243-6. doi: 10.1007/s10840-007-9124-y. Epub 2007 Jun 2.